Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sen. Burr Worries Rising User Fees Helping US FDA Evade Congressional Oversight
Apr 06 2022
•
By
Derrick Gingery
Sen. Richard Burr, R-N.C., wants more FDA accountability in its user fee programs. • Source: screenshot
More from User Fees
More from Pathways & Standards